Table 1 Demographic, imaging, and clinical characteristics of the study participants

Age, years

63.5 (4.8)

63.9 (4.3)

63.3 (4.9)

Female,n(%)

153 (61.2)

43 (61.4)

110 (61.1)

Family history of sporadic AD,n(%)^a

197 (89.1)

53 (75.7)

144 (80)

Caucasian,n(%)

248 (99.2)

68 (97.1)

180 (100)

Education, years

13.3 (3.5)

13.8 (3.4)

13.1 (3.5)

Aβ-positive (≥ 12CL),n(%)^b

26 (12.7)

7 (10)

19 (10.6)

SCD-Q, MyCog scores^c

4.1 (4.4)

8.2 (4.5)

2.5 (3.1)

Pre-confinement HADS total scores

6.6 (4.8)

8.3 (5.1)

6 (4.5)

Confinement HADS total scores

8.1 (5.9)

9.4 (6.1)

7.6 (5.7)

PSS scores^d

16.1 (8.6)

18 (9.1)

15.4 (8.3)

BRS scores^e

3.2 (0.4)

3.1 (0.3)

3.2 (0.4)

Change in HADS from pre-confinement to confinement

1.5 (5.8)

1.1 (5.2)

1.6 (5.9)

Currently diagnosed/under treatment for anxiety/depression,n(%)^f

26 (10.4)

9 (12.9)

17 (9.4)

Seeking medical help due to the self-perceived decline in cognition

22 (8.8)

22 (31.4)

–